Le nombre de patients immunodéprimés ne cesse d'augmenter en raison de l'amélioration
du pronostic global du cancer et de l'utilisation croissante d'immunosuppresseurs tant en …

Les infections et les né oplasies sont les consé quences attendues du traitement
immunosuppresseur, qui diminue les ré ponses cellulaires et humorales de façon non spé …

Results Five patients were included, all of whom were deceased donor LT recipients. Their
baseline characteristics are described in Table 1. Pretransplant IGRA screening for latent TB …

Transmission of tuberculosis (TB) from a deceased solid organ donor to recipients can result
in severe morbidity and mortality. In 2018, four solid organ transplant recipients residing in …

Background Tuberculosis (TB) is a major complication following transplantation. The
likelihood of TB may be increased in transplant patients living in TB‐endemic areas such as …

Abstract Introduction: Tuberculosis incidence in Portugal ranged from 20 to 22 cases per
100 000 inhabitants between 2010 and 2014. Tuberculosis incidence in liver transplant …

Objective: Latent tuberculosis infection (LTBI) screening is strongly recommended in the pre-
transplant evaluation of solid organ transplant (SOT) recipients, although it remains …

Résumé Les infections et les néoplasies sont les conséquences attendues du traitement
immunosuppresseur, qui diminue les réponses cellulaires et humorales de façon non …

Accurate prediction of which patient will progress from a sub-clinical Mycobacterium
tuberculosis infection to active tuberculosis represents an elusive, yet critical, clinical …

Aim: Immunosuppressive drugs predispose the liver transplant recipient to reactivation of
latent tuberculosis infections. Prophylactic therapies given to these patients are very …